Table 2. Distribution of different outcomes according to two arms in addition to related effect sizes.
| Clinical Outcome | PPT group (n = 19) | Basic care group (n = 18) | F (P value) ** | MD [95% CI] | SMD [95% CI] | Partial eta2 | ||
|---|---|---|---|---|---|---|---|---|
| Baseline* | After* | Baseline* | After* | |||||
| pO2 (mmHg) | 29.4 ± 5.3 | 38.7 ± 5.3 | 30.6 ± 8.2 | 32.9 ± 7.5 | 7.5 (< .01) a | 5.81 [1.51, 10.11] | .9 [.21, 1.57] | .177 |
| 13 (< .01) b | 6.43 [2.8, 10.07] | 1.18 [.48, 1.88] | .276 | |||||
| 12.04 (< .01) c | 6.39 [2.64, 10.14] | 1.15 [.45, 1.84] | .267 | |||||
| pCO2 (mmHg) | 40 ± 7.3 | 37 ± 7.2 | 39.3 ± 8 | 38.6 ± 8.1 | .44 (.51) a | -1.68 [-6.8, 3.44] | -.22 [-.43, .86] | .012 |
| .97 (.33) b | -2.1 [-6.36, 2.21] | -.32 [-.97, .33] | .027 | |||||
| .62 (.44) c | -1.7 [-6.01, 2.65] | -.26 [-.91, 39] | .018 | |||||
| Spo2 (Free air) (%) | 83.4 ± 4.9 | 90.21 ± 3.4 | 84.4 ± 3.9 | 86.2 ± 4 | 10.63 (< .01) a | 3.99 [1.5, 6.47] | 1.07 [.37, 1.76] | .233 |
| 14.2 (< .01) b | 4.43 [2.04, 6.83] | 1.25 [.53, 1.95] | .294 | |||||
| Distance of 3MWT (m) | 46 ± 24.3 | 149.1 ± 63 | 50 ± 24.4 | 67.3 ± 33.1 | 24.03 (< .01) a | 81.82 [47.93, 115.7] | 1.61 [.86, 2.35] | .407 |
| 67.9 (< .01) b | 91.44 [68.88, 113.99] | 2.72 [1.81, 3.62] | .666 | |||||
| 64.33 (< .01) c | 91.62 [68.38, 114.86] | 2.67 [1.76, 3.55] | .661 | |||||
| Level of Dyspnea | 5 ± 2 | 1.54 ± 1.2 | 5.19 ± 1.4 | 3.6 ± 1.5 | 22.89 (< .01) a | -2.08 [-2.96, -1.19] | -1.57 [-2.31, -.82] | .395 |
| 38.44 (< .01) b | -1.98 [-2.63, -1.33] | -2.04 [-2.83, -1.23] | .531 | |||||
| 36.54 (< .01) c | -1.99 [-2.66, -1.32] | -2 [-2.79, -1.2] | .525 | |||||
| RPE after Walking | 16.2 ± 1.6 | 10.8 ± 3 | 17 ± 1.3 | 14.8 ± 2 | 22.6 (< .01) a | -4.04 [-5.76, -2.32] | -1.56 [-2.3, -.82] | .393 |
| 18 (< .01) b | -3.46 [-5.12, -1.8] | -1.42 [-2.14, -.69] | .346 | |||||
| 15.67 (< .01) c | -3.32 [-5.03, -1.62] | -1.34 [-2.05, -.62] | .322 | |||||
| PH from VBG | 7.42 ± .08 | 7.5 ± .07 | 7.44 ± .06 | 7.43 ± .1 | 5.11 (.03) a | .06 [.01, .12] | .74 [.71, 1.41] | .127 |
| 8.38 (< .01) b | .08 [.02, .13] | .96 [.27, 1.63] | .198 | |||||
| 7.31 (< .01) c | .07 [.02, .13] | .9 [.22, 1.57] | .181 | |||||
PPT: Pulmonary physiotherapy; pO2: Mixed venous O2 pressure; pCO2: Mixed venous CO2 pressure; Spo2: Oxygen saturation; 3MWT: Three-minute walk test; RPE: Rating of perceived exertion; VBG: Venous blood gas; MD: Mean difference; CI: Confidence interval; SMD: Standardized mean difference (based on Cohen’s d test), ANOVA: Analysis of variance, ANCOVA: Analysis of covariance.
* Expressed as mean ± standard deviation. The baseline and after values present the result of participants’ assessment before and after three days, respectively.
** Analyzed using ANOVA/ANCOVA tests. F statistics and P value were reported based on Group source analysis.
a Crude analysis.
b Adjusted to baseline measurement of the variable (as covariance).
c Adjusted t baseline measurement of the variable and baseline O2 saturation (free air) (as covariance).